Trop2 deal heats up antibody-drug conjugate space in cancer

Nat Biotechnol. 2021 Feb;39(2):128-130. doi: 10.1038/s41587-021-00824-8.
No abstract available

Publication types

  • News

MeSH terms

  • Antigens, Surface / metabolism*
  • Clinical Trials as Topic
  • Drug Industry
  • Humans
  • Immunoconjugates / therapeutic use*
  • Molecular Targeted Therapy
  • Neoplasms / drug therapy*

Substances

  • Antigens, Surface
  • Immunoconjugates